Articles related to DRUG SAFETY & INTERACTIONS

In oncology, the balance between rapid innovation and patient safety is critical. The recent withdrawal of an accelerated approval cancer drug highlights the need for more stringent evidence and robust trial design to truly benefit patients.

In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.

Explore the vital link between EHR usability and patient safety. Recent data from 112 US hospitals reveals a significant correlation, emphasizing the need for improved usability to enhance medication safety.

As healthcare professionals, it’s crucial to understand that PDE5 inhibitors, commonly prescribed for erectile dysfunction and pulmonary arterial hypertension, have been linked to retinal and vision changes. This highlights the importance of monitoring patients on these medications closely.

New research indicates that coffee can interact with certain medications including ephedrine, antidiabetic drugs, theophylline, and phenothiazines.

This study highlights a potential risk associated with benzodiazepine treatment in high-risk individuals. Learn more about how this could impact your practice.